ArticleDiabetes & metabolism journal2024
Does Rosuvastatin/Ezetimibe Combination Therapy Offer Potential Benefits for Glucose Metabolism beyond Lipid-Lowering Efficacy in T2DM?
Il Rae Park et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.